This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Helena Laboratories Corporation. Active years: 1984-1993.
Company Filing History:
Years Active: 1984-1993
Title: Innovations by Janine P Burrows
Introduction
Janine P Burrows is a notable inventor based in Orange, Texas. She has made significant contributions to the field of medical testing, particularly in the development of fecal occult blood tests. With a total of four patents to her name, her work has the potential to impact healthcare practices significantly.
Latest Patents
Among her latest innovations is a fecal occult blood test product that includes both positive and negative controls. This test sheet is designed to determine the presence of substances with peroxidase-like activity in a throw-in-the-bowl fecal occult blood test. The test area features a specially formulated test ink that contains at least one oxygen donor reagent and a chromogen reagent. These components work together to produce a visually observable color change in the presence of blood or similar substances. Additionally, the test ink incorporates a water-soluble polymer to immobilize the chromogen and oxygen donor, ensuring accurate results. The positive control area is similarly treated to validate the test's effectiveness.
Career Highlights
Janine is currently employed at Helena Laboratories Corporation, where she continues to innovate and develop new medical testing solutions. Her work is characterized by a commitment to improving diagnostic accuracy and patient care.
Collaborations
Throughout her career, Janine has collaborated with esteemed colleagues, including Philip A Guadagno and David L Tabb. These partnerships have fostered a collaborative environment that enhances the quality and impact of her inventions.
Conclusion
Janine P Burrows exemplifies the spirit of innovation in the medical field. Her contributions, particularly in fecal occult blood testing, demonstrate her dedication to advancing healthcare technology. Her work continues to pave the way for improved diagnostic methods and better patient outcomes.